This webinar focuses on the GLADIATOR project. GLADIATOR envisions to establish a radical long-term vision leading to a drastic change in cancer monitoring and therapy. It will usher in a paradigm shift in Oncology, with the introduction of "bio-nano-machine diagnostics", and stimulate the implementation of the "Internet of Nano-bio-things", leading to technological and clinical developments with high socioeconomic impact. In this project the role of the team at Walton Institute is to develop an end to end molecular communication system for inter-cellular communication among brain cells. It is expected that the project’s results will substantially improve patient prognosis and prolong survival by minimizing recurrences and reducing drug toxicity.